Cloud-based solutions for drug discovery, development and manufacturing market is projected to grow at a CAGR of 15.4%, claims Roots Analysis
The growing complexities surrounding modern therapy development initiatives have caused biopharmaceutical companies to adopt available cloud-based solutions, to not only expedite associated timelines, but also cuts down overall cost   Roots Analysis has announced the addition of “Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market by Type of Cloud (Private,...
0 Commentaires 0 Parts